Aries Wealth Management Astrazeneca PLC Transaction History
Aries Wealth Management
- $409 Million
- Q3 2025
A detailed history of Aries Wealth Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Aries Wealth Management holds 9,248 shares of AZN stock, worth $826,771. This represents 0.17% of its overall portfolio holdings.
Number of Shares
9,248
Previous 9,548
3.14%
Holding current value
$826,771
Previous $667,000
6.3%
% of portfolio
0.17%
Previous 0.18%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,507Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...